Vredenburgh, J. J., Desjardins, A., Reardon, D. A., Peters, K., Kirkpatrick, J., Coan, A. D., … Friedman, H. S. (2011). Bevacizumab, temozolomide, and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly-diagnosed glioblastoma multiforme (GBM). JOURNAL OF CLINICAL ONCOLOGY, 29(15).

Vredenburgh, J. J., A. Desjardins, D. A. Reardon, K. Peters, J. Kirkpatrick, A. D. Coan, L. Bailey, D. Janney, C. Lu, and H. S. Friedman. “Bevacizumab, temozolomide, and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly-diagnosed glioblastoma multiforme (GBM).” JOURNAL OF CLINICAL ONCOLOGY 29, no. 15 (May 20, 2011).

Vredenburgh JJ, Desjardins A, Reardon DA, Peters K, Kirkpatrick J, Coan AD, et al. Bevacizumab, temozolomide, and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly-diagnosed glioblastoma multiforme (GBM). JOURNAL OF CLINICAL ONCOLOGY. 2011 May 20;29(15).

Vredenburgh, J. J., et al. “Bevacizumab, temozolomide, and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly-diagnosed glioblastoma multiforme (GBM).” JOURNAL OF CLINICAL ONCOLOGY, vol. 29, no. 15, AMER SOC CLINICAL ONCOLOGY, May 2011.

Vredenburgh JJ, Desjardins A, Reardon DA, Peters K, Kirkpatrick J, Coan AD, Bailey L, Janney D, Lu C, Friedman HS. Bevacizumab, temozolomide, and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly-diagnosed glioblastoma multiforme (GBM). JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2011 May 20;29(15).